Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Published 26/05/2023, 13:50
Updated 26/05/2023, 15:10
© Reuters.  Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

© Reuters. Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Benzinga - Gainers

  • Oncorus, Inc. (NASDAQ: ONCR) shares rose 90% to $0.38 in pre-market trading after dropping around 17% on Thursday. Oncorus recently posted a narrower-than-expected quarterly loss.
  • eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares surged 67.6% to $0.8866 in pre-market trading as the company reported data updates from Phase 2 expansion cohorts evaluating zotatifin in patients with ER+ metastatic breast cancer at the ASCO 2023 Annual Meeting.
  • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) gained 45.4% to $1.73 in pre-market trading after dropping 8% on Thursday. Shuttle Pharmaceuticals was recently granted U.S. patent #11654157: Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation.
  • Arcus Biosciences, Inc. (NYSE: RCUS) gained 26.5% to $22.14 in pre-market trading. Arcus Biosciences announced new employment inducement grants.
  • Harbor Custom Development, Inc. (NASDAQ: HCDI) shares gained 24.1% to $4.64 in pre-market trading. Harbor Custom Development recently issued an update on the Company’s six multi-family projects.
  • Elevation Oncology, Inc. (NASDAQ: ELEV) shares gained 21.2% to $3.65 in pre-market trading after adding over 15% on Thursday.
  • Marvell Technology, Inc. (NASDAQ: MRVL) rose 15.9% to $57.34 in pre-market trading after the company reported strong Q1 results and said it expects AI revenue to at least double in 2024.
  • PDS Biotechnology Corporation (NASDAQ: PDSB) rose 15.5% to $7.76 in pre-market trading. PDS Biotechnology announced promising interim data from the VERSATILE-002 Phase 2 clinical trial.
  • Angion Biomedica Corp. (NASDAQ: ANGN) shares climbed 13% to $0.9601 in pre-market trading after gaining around 4% on Thursday.
  • The Gap, Inc. (NYSE: GPS) shares rose 11.8% to $8.30 in pre-market trading after the retailer turned in a profitable quarter on an adjusted basis, despite analysts forecasting a significant loss.
Losers
  • SunCar Technology Group Inc. (NASDAQ: SDA) fell 24.5% to $11.37 in pre-market amid continued volatility following the recent completion of the company's combination with Goldenbridge Acquisition to become a publicly-traded company.
  • Beamr Imaging Ltd. (NASDAQ: BMR) shares dropped 19.1% to $4.01 in pre-market trading. Beamr Imaging shares jumped 125% on Thursday after NVIDIA announced the release of NVENC Video Codec SDK 12.1 showcasing the integration with Beamr CABR.
  • Tilray Brands, Inc. (NASDAQ: TLRY) fell 18.6% to $1.92 in pre-market trading after the company raised $150 million via unsecured convertible senior notes offering.
  • Wearable Devices Ltd. (NASDAQ: WLDS) fell 17.7% to $1.16 in pre-market trading. Wearable Devices shares jumped over 222% on Thursday after the company announced its Mudra Band for Apple Watch is available for preorder.
  • Peraso Inc. (NASDAQ: PRSO) fell 17.4% to $0.4050 in pre-market trading after jumping 21% on Thursday.
  • Nano Labs Ltd (NASDAQ: NA) fell 14.7% to $2.02 in pre-market trading after climbing over 69% on Thursday.
  • Infobird Co., Ltd (NASDAQ: IFBD) shares dropped 12.4% to $1.20 in pre-market trading after climbing 23% on Thursday.
  • Evoke Pharma, Inc. (NASDAQ: EVOK) fell 11.2% to $1.66 in pre-market trading. Evoke Pharma recently posted a wider-than-expected quarterly loss.
  • Lizhi Inc. (NASDAQ: LIZI) shares fell 9.8% to $0.74 in pre-market trading. Lizhi shares jumped 17% on Thursday after releasing first-quarter results.
  • X Financial (NYSE: XYF) fell 8.7% to $3.25 in pre-market trading after jumping around 15% on Thursday.

Now Read This: Investor Sentiment Improves Following Strong Results From Nvidia

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.